Miniaturized ligand binding assays enable scientists to do more with less
27 Feb 2026
Gyros Protein Technologies is driven by a clear mission: to accelerate drug development by miniaturizing ligand binding assays so scientists can do more with less. This focus on productivity and efficiency underpins the development of tools that help researchers overcome challenges such as limited sample volumes and tight timelines. The GyroLab xPlore™ exemplifies this approach, delivering an end‑to‑end workflow in an hour. In this SelectScience interview, hear from Senior Field Application Scientist Eric Feely, as he discusses how the team continues to advance automation technologies and collaborate with automation groups to further streamline and accelerate laboratory workflows.
This video was filmed at SLAS 2026.
About the company
Gyros Protein Technologies
Gyros Protein Technologies provides enabling peptide synthesis and bioanalytical solutions, helping scientists in research through bioprocess applications. Our peptide synthesizers and chemistries deliver uncompromising purity, flexibility and quality in less time. Sensitive, accurate and robust nanoliter-scale immunoassays for pharmacokinetics/pharmacodynamics, immunogenicity and quantitating bioprocess impurities and viral titer are performed on our proprietary platforms. Peptide synthesis and bioanalytical solutions: accelerate your discovery, development and manufacturing of safer biotherapeutics. Gyros Protein Technologies is a division of Mesa Laboratories. www.gyrosproteintechnologies.com
Related products
Request Quote for All Products
Gyrolab xPlore™ immunoassay system
Gyros Protein TechnologiesGyrolab xPlore is a single-CD, cost-effective microfluidic immunoassay platform for unattended parallel processing of 96 or 112 data points in one hour.
